Long-term follow-up of the EGEA cohort on respiratory and cardiac health
EGEA4: the 30-year Follow-up of the EGEA Study : Study of Markers of Cardiovascular Risk in Asthmatic and Non-asthmatic
This study looks at how asthma might affect heart health over time by following a group of people and collecting different health information from them.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France Government |
| Locations | 5 sites (Grenoble and 4 other locations) |
| Trial ID | NCT06334705 on ClinicalTrials.gov |
What this trial studies
This study focuses on the long-term follow-up of participants from the EGEA cohort to investigate the relationship between asthma and cardiovascular diseases. It aims to understand the potential shared risk factors and mechanisms linking these conditions, utilizing various interventions such as blood tests, food and hair collection, and calcium scans. The study seeks to gather comprehensive epidemiological data to better understand the impact of asthma on cardiovascular health over time.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have previously participated in the EGEA surveys and are affiliated with a social security scheme.
Not a fit: Patients who are currently deprived of liberty or under legal protection measures may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights that lead to improved prevention and treatment strategies for patients with asthma and cardiovascular diseases.
How similar studies have performed: Other studies have indicated a potential link between asthma and cardiovascular diseases, but this specific long-term follow-up approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have participated in at least one of the previous EGEA surveys; * to be affiliated to a social security scheme or to be a beneficiary of such a scheme. Exclusion Criteria: * Person deprived of liberty by judicial or administrative decision; * Person subject to a legal protection measure (safeguard of justice, curatorship or guardianship).
Where this trial is running
Grenoble and 4 other locations
- Centre Hospitalier Universitaire Grenoble Alpes — Grenoble, France (Recruiting)
- Hopital de la Croix Rousse — Lyon, France (Recruiting)
- Aphm — Marseille, France (Recruiting)
- Hôpital Arnaud De Villeneuve — Montpellier, France (Recruiting)
- APHP - Hôpital Bichat Claude Bernard — Paris, France (Recruiting)
Study contacts
- Principal investigator: Valérie Siroux, PHD — Institut National de la Santé Et de la Recherche Médicale, France
- Study coordinator: Valérie Siroux, PHD
- Email: valerie.siroux@univ-grenoble-alpes.fr
- Phone: 0476549451
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.